Background. Amino acid transport imaging with 18F-FDOPA PET is increasingly used for detection of glioblastoma recurrence. However, a standardized image interpretation for 18F-FDOPA brain PET studies has not yet been established. This study compares visual and semi-quantitative analysis parameters for detection of tumor recurrence and correlates them with progression-free survival (PFS). Methods.One-hundred ten patients (72 male:38 female) with suspected tumor recurrence who underwent 18F-FDOPA PET imaging were studied. PETscans were analyzed visually (5-point scale) and semiquantitatively (lesion-to-striatum- and lesion- to-normal-brain-tissue ratios using both SUVmean and SUVmax). Accuracies for recurrence detection were calculated using ...
In glioma patients, differentiation between tumor progression (TP) and treatment-related changes (TR...
Item does not contain fulltext3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) is a radiopharmaceutical...
Purpose: This pilot study aimed to evaluate the amino acid tracer 18F-FACBC with simultaneous PET/MR...
Background: MRI-based differential diagnosis of glioma recurrence (GR) and treatment-induced changes...
The assessment of treatment response in glioblastoma is difficult with MRI because reactive blood-br...
Purpose: Response evaluation in patients with glioblastoma after chemoradiotherapy is challenging du...
International audienceBackground: Static [18F]-F-DOPA PET images are currently used for identifying ...
The PET tracer O-(2-[18F]Fluoroethyl)-l-tyrosine (FET) has been shown to be valuable for different r...
6-18F-fluoro-L-dopa (18F-FDOPA) measured with PET as a bio-marker of amino acid uptake has been inve...
Background: Recurrence in glioblastoma patients often occur close to the original tumour and indicat...
none8noAim: To investigate the progression-free survival (PFS) and the overall survival (OS) in a po...
The ability to accurately differentiate treatment-related changes (ie, pseudoprogression and radiati...
In glioma patients, differentiation between tumor progression (TP) and treatment-related changes (TR...
3-Deoxy-3-18F-fluorothymidine (18F-FLT) is a recently devel-oped PET tracer to image tumor cell prol...
BACKGROUND AND PURPOSE: Inter- and intratumor heterogeneity and the variable course of disease in pa...
In glioma patients, differentiation between tumor progression (TP) and treatment-related changes (TR...
Item does not contain fulltext3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) is a radiopharmaceutical...
Purpose: This pilot study aimed to evaluate the amino acid tracer 18F-FACBC with simultaneous PET/MR...
Background: MRI-based differential diagnosis of glioma recurrence (GR) and treatment-induced changes...
The assessment of treatment response in glioblastoma is difficult with MRI because reactive blood-br...
Purpose: Response evaluation in patients with glioblastoma after chemoradiotherapy is challenging du...
International audienceBackground: Static [18F]-F-DOPA PET images are currently used for identifying ...
The PET tracer O-(2-[18F]Fluoroethyl)-l-tyrosine (FET) has been shown to be valuable for different r...
6-18F-fluoro-L-dopa (18F-FDOPA) measured with PET as a bio-marker of amino acid uptake has been inve...
Background: Recurrence in glioblastoma patients often occur close to the original tumour and indicat...
none8noAim: To investigate the progression-free survival (PFS) and the overall survival (OS) in a po...
The ability to accurately differentiate treatment-related changes (ie, pseudoprogression and radiati...
In glioma patients, differentiation between tumor progression (TP) and treatment-related changes (TR...
3-Deoxy-3-18F-fluorothymidine (18F-FLT) is a recently devel-oped PET tracer to image tumor cell prol...
BACKGROUND AND PURPOSE: Inter- and intratumor heterogeneity and the variable course of disease in pa...
In glioma patients, differentiation between tumor progression (TP) and treatment-related changes (TR...
Item does not contain fulltext3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) is a radiopharmaceutical...
Purpose: This pilot study aimed to evaluate the amino acid tracer 18F-FACBC with simultaneous PET/MR...